Literature DB >> 31909475

Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.

Jeremy A Goss1, Dennis J Konczyk1, Patrick Smits1, Christopher L Sudduth1, Joyce Bischoff2, Marilyn G Liang3, Arin K Greene1.   

Abstract

Diffuse capillary malformation with overgrowth (DCMO) is a clinical diagnosis describing patients with multiple, extensive capillary malformations (CMs) associated with overgrowth and foot anomalies. The purpose of the study was to identify somatic variants in DCMO. Skin containing CM and overgrown subcutaneous adipose tissue was collected from patients with DCMO. Exons from 447 cancer-related genes were sequenced using OncoPanel. Variant-specific droplet digital PCR (ddPCR) independently confirmed the variants and determined variant allele frequencies (VAF). One subject contained a somatic PIK3CA p.G106V variant. A second patient had a PIK3CA p.D350G variant. VAF was 27% to 29% in skin and 16% to 28% in subcutaneous adipose. Variants were enriched in endothelial cells (VAF 50%-51%) compared to nonendothelial cells (1%-8%). DCMO is associated with somatic PIK3CA variants and should be considered on the PIK3CA-related overgrowth spectrum (PROS). Variants are present in both skin and subcutaneous adipose and are enriched in endothelial cells.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PIK3CA-related overgrowth spectrum; capillary malformation; genetic association studies; humans; mutation; phosphatidylinositol 3-kinases; vascular malformations

Mesh:

Substances:

Year:  2020        PMID: 31909475      PMCID: PMC8128061          DOI: 10.1111/cge.13702

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  28 in total

1.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

2.  Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

Authors:  Linghua Wang; Shuichi Tsutsumi; Tokuichi Kawaguchi; Koichi Nagasaki; Kenji Tatsuno; Shogo Yamamoto; Fei Sang; Kohtaro Sonoda; Minoru Sugawara; Akio Saiura; Seiko Hirono; Hiroki Yamaue; Yoshio Miki; Minoru Isomura; Yasushi Totoki; Genta Nagae; Takayuki Isagawa; Hiroki Ueda; Satsuki Murayama-Hosokawa; Tatsuhiro Shibata; Hiromi Sakamoto; Yae Kanai; Atsushi Kaneda; Tetsuo Noda; Hiroyuki Aburatani
Journal:  Genome Res       Date:  2011-12-07       Impact factor: 9.043

3.  PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.

Authors:  Kim M Keppler-Noreuil; Jonathan J Rios; Victoria E R Parker; Robert K Semple; Marjorie J Lindhurst; Julie C Sapp; Ahmad Alomari; Marybeth Ezaki; William Dobyns; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2014-12-31       Impact factor: 2.802

4.  Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

Authors:  Elizabeth P Garcia; Alissa Minkovsky; Yonghui Jia; Matthew D Ducar; Priyanka Shivdasani; Xin Gong; Azra H Ligon; Lynette M Sholl; Frank C Kuo; Laura E MacConaill; Neal I Lindeman; Fei Dong
Journal:  Arch Pathol Lab Med       Date:  2017-03-03       Impact factor: 5.534

5.  Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

Authors:  Ludovic Barault; Nicolas Veyrie; Valerie Jooste; Delphine Lecorre; Caroline Chapusot; Jean-Marc Ferraz; Astrid Lièvre; Marion Cortet; Anne-Marie Bouvier; Patrick Rat; Patrick Roignot; Jean Faivre; Pierre Laurent-Puig; Francoise Piard
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

6.  Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Authors:  Quitterie Venot; Thomas Blanc; Smail Hadj Rabia; Laureline Berteloot; Sophia Ladraa; Jean-Paul Duong; Estelle Blanc; Simon C Johnson; Clément Hoguin; Olivia Boccara; Sabine Sarnacki; Nathalie Boddaert; Stephanie Pannier; Frank Martinez; Sato Magassa; Junna Yamaguchi; Bertrand Knebelmann; Pierre Merville; Nicolas Grenier; Dominique Joly; Valérie Cormier-Daire; Caroline Michot; Christine Bole-Feysot; Arnaud Picard; Véronique Soupre; Stanislas Lyonnet; Jeremy Sadoine; Lotfi Slimani; Catherine Chaussain; Cécile Laroche-Raynaud; Laurent Guibaud; Christine Broissand; Jeanne Amiel; Christophe Legendre; Fabiola Terzi; Guillaume Canaud
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962

7.  Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.

Authors:  Marjorie J Lindhurst; Victoria E R Parker; Felicity Payne; Julie C Sapp; Simon Rudge; Julie Harris; Alison M Witkowski; Qifeng Zhang; Matthijs P Groeneveld; Carol E Scott; Allan Daly; Susan M Huson; Laura L Tosi; Michael L Cunningham; Thomas N Darling; Joseph Geer; Zoran Gucev; V Reid Sutton; Christos Tziotzios; Adrian K Dixon; Timothy Helliwell; Stephen O'Rahilly; David B Savage; Michael J O Wakelam; Inês Barroso; Leslie G Biesecker; Robert K Semple
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

8.  A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth.

Authors:  Javier A Couto; Ugur M Ayturk; Dennis J Konczyk; Jeremy A Goss; August Y Huang; Steve Hann; Jennifer L Reeve; Marilyn G Liang; Joyce Bischoff; Matthew L Warman; Arin K Greene
Journal:  Angiogenesis       Date:  2017-01-24       Impact factor: 9.596

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

10.  Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.

Authors:  Victoria E R Parker; Kim M Keppler-Noreuil; Laurence Faivre; Pierre Vabres; Robert K Semple; Leslie G Biesecker; Maxime Luu; Neal L Oden; Leena De Silva; Julie C Sapp; Katrina Andrews; Marc Bardou; Kong Y Chen; Thomas N Darling; Elodie Gautier; Barry R Goldspiel; Smail Hadj-Rabia; Julie Harris; Georgios Kounidas; Parag Kumar; Marjorie J Lindhurst; Romaric Loffroy; Ludovic Martin; Alice Phan; Kristina I Rother; Brigitte C Widemann; Pamela L Wolters; Christine Coubes; Lucile Pinson; Marjolaine Willems; Catherine Vincent-Delorme
Journal:  Genet Med       Date:  2018-10-01       Impact factor: 8.822

View more
  4 in total

1.  Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study.

Authors:  Andrea Diociaiuti; Roberta Rotunno; Elisa Pisaneschi; Claudia Cesario; Claudia Carnevale; Angelo Giuseppe Condorelli; Massimo Rollo; Stefano Di Cecca; Concetta Quintarelli; Antonio Novelli; Giovanna Zambruno; May El Hachem
Journal:  Biomedicines       Date:  2022-06-20

2.  Vascular Malformations: Current Progress Toward Drug Therapy.

Authors:  Arin K Greene; Christopher L Sudduth
Journal:  J Craniofac Surg       Date:  2021-05-01       Impact factor: 1.046

3.  Primary Lymphedema: Update on Genetic Basis and Management.

Authors:  Christopher L Sudduth; Arin K Greene
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-01-27       Impact factor: 4.947

Review 4.  A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations.

Authors:  Guillaume Canaud; Adrienne M Hammill; Denise Adams; Miikka Vikkula; Kim M Keppler-Noreuil
Journal:  Orphanet J Rare Dis       Date:  2021-07-08       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.